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Objectives. Human age-dependent telomere attrition
and telomere shortening are associated with sev-
eral age-associated diseases and poorer overall
survival. The aim of this study was to determine
longitudinal leucocyte telomere length dynamics
and identify factors associated with temporal
changes in telomere length.
Design and Methods. Leucocyte telomere length was
measured by quantitative polymerase chain reac-
tion in 8074 participants from the Prevention of
Renal and Vascular End-stage Disease (PREVEND)
study, an ongoing community-based prospective
cohort study initiated in 1997. Follow-up data were
available at two time-points up to 2007. Leucocyte
telomere length was measured, on between one
and three separate occasions, in a total of 16 783
DNA samples. Multilevel growth models were cre-
ated to identify the factors that influence leucocyte
telomere dynamics.
Results. We observed an average attrition rate of
0.47  0.16 relative telomere length units (RTLUs)
per year in the study population aged 48 (range 39–
60) years at baseline. Annual telomere attrition rate
increased with age (P < 0.001) and was faster on
average in men than in women (P for interaction
0.043). The major independent factors determining
telomere attrition rate were active smoking (approx-
imately tripled the lossofRTLUperyear,P < 0.0001)
and multiple traits of the metabolic syndrome
(waist–hip ratio, P = 0.007; blood glucose level,
P = 0.045, and HDL cholesterol level, P < 0.001).
Conclusions. Smoking and variables linked to the
metabolic syndrome are modifiable lifestyle factors
that accelerate telomere attrition in humans. The
higher rate of cellular ageing may mediate the link
between smoking and the metabolic syndrome to
an increased risk of several age-associated dis-
eases.
Keywords: ageing, biomarker, metabolic syndrome,
smoking, telomeres.
Introduction
Telomeres are DNA–protein complexes at the ter-
minal ends of linear chromosomes that consist of a
large number of tandem repeats of a simple DNA
sequence (TTAGGG in humans) and are capped by
interacting with a protein complex (known as
shelterin) [1–3]. Telomeres are essential structures
involved in the protection and maintenance of
chromosomal stability and are involved in cell
cycle control. Telomere length shows considerable
interindividual variation at birth. Both in vitro and
in vivo in somatic cells, telomeres shorten progres-
sively with repeated cell divisions and therefore
with cellular replicative age. When the mean telo-
mere length reaches a critical value, a DNA damage
signal is generated, causing arrest of cell prolifer-
ation, senescence and apoptosis. Consequently,
telomere length has been proposed as a marker of
variation in biological ageing [1–3].*These authors contributed equally to this study.
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A number of epidemiological observations support
this proposal. Although some data are conflicting,
in general individuals with longer telomeres have
been found to have better health and live longer
than those with shorter telomeres [4–9]. An adverse
association has now been shown in a considerable
number of studies between shorter leucocyte telo-
mere length and ageing-associated diseases,
including cancer [8], coronary heart disease [10,
11] and heart failure [12]. For example, patients
with coronary artery disease have telomere lengths
comparable to those of healthy individuals who are
approximately 10 years older [10, 11].
An association between leucocyte telomere length
and demographic variables as well as lifestyle
factors has been shown in several cross-sectional
studies [3, 13, 14]. However, whether these fac-
tors affect telomere attrition has not been estab-
lished; to do so would require longitudinal studies
with serial measurements of telomere length in
the same subjects. Therefore, in the present
study, we investigated the dynamics of leucocyte
telomere length in a large population-based cohort
with longitudinal follow-up to identify the factors




This analysis was performed within the framework
of the Prevention of Renal and Vascular End-Stage
Disease (PREVEND, www.prevend.org) study. The
PREVEND study is an ongoing, longitudinal, gen-
eral, population-based cohort study of individuals
aged 28–75 years living in the city of Groningen,
the Netherlands. For the present study, we
included subjects who donated a full blood sample
for DNA extraction at baseline (T1) and/or during
the first (T2) and/or the second (T3) follow-up visit.
Details of the study have been described previously
[15]. In brief, 8592 subjects completed the baseline
survey (1997–1998) and were invited to visit the
outpatient department after approximately
4.3 years for the first and approximately 6.6 years
for the second follow-up visit. At each visit, demo-
graphic and anthropometric characteristics and
serum biomarkers were assessed. The PREVEND
study has been approved by the local medical
ethics committee and is being conducted in accor-
dance with the guidelines of the Declaration of
Helsinki. All participants provided written
informed consent before enrolment.
Measurement of telomere length
Details of the methods of DNA extraction and of
telomere length measurements are provided in the
Appendix S1. In brief, all samples for DNA col-
lected at different time-points were mixed and
randomly extracted using a standard DNA extrac-
tion kit (QIamp, Qiagen, Venlo, the Netherlands) to
neutralize potential batch effects. Mean relative
leukocyte telomere length was measured using a
monochrome multiplex real-time quantitative poly-
merase chain reaction technique (developed by
R.M.C.) [16]. This technique enables the telomere-
specific amplification and the single copy gene
(reference) amplification to be carried out in a
single reaction well with quantification measure-
ments at different temperatures [16]. The ratio of
telomere (T) to single copy gene (S) content (T/S
ratio) is a relative measure of telomere length (RTL)
and is expressed in arbitrary units (RTLU). All
samples were measured in triplicate, and the
average of the three runs was used to provide the
mean RTLU for each individual. The intra-assay
coefficients of variation were 2.0%, 1.9% and 4.5%
for T, S and the T/S ratio, respectively.
We adhered to the arbitrary categorization of
telomere trajectories as previously reported: short-
ening was defined as a >10% decrease in RTL,
stable as a ≤10% change in RTL and elongation as a
>10% increase in RTL at T3 compared to baseline
[17, 18].
Other measurements and definitions
All participants completed a questionnaire regard-
ing demographic profile and smoking habits.
Smoking was categorized as current smoking,
previous smoking and nonsmoking. Body mass
index (BMI) was calculated as weight (kg) divided
by height squared (m2) and categorized as follows:
normal, <25 kg m2; overweight, 25–30 kg m2;
and obese, ≥30 kg m2. Hypertension was defined
as systolic blood pressure ≥140 mmHg, diastolic
blood pressure ≥90 mmHg or the use of antihyper-
tensive medication; prehypertension was defined
as systolic blood pressure <140 and ≥120 mmHg
and diastolic blood pressure <90 and ≥80 mmHg;
and normotension was defined as both systolic
blood pressure <120 mmHg and diastolic blood
pressure <80 mmHg. Diabetes was defined as a
fasting plasma glucose level of ≥126 mg dL1
(7.0 mmol L1), a nonfasting plasma glucose level
of ≥200 mg dL1 (11.1 mmol L1) or the use of oral
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antidiabetic agents. Hypercholesterolaemia was
defined as a total cholesterol level of ≥250 mg dL1
(6.5 mmol L1) or the use of lipid-lowering
medication; ≤200 mg dL1 (5.13 mmol L1) was
considered an optimal cholesterol concentration.
Estimated glomerular filtration rate (eGFR) was
calculated using the Modification of Diet in Renal
Disease (MDRD) study equation taking into
account sex, age, ethnicity and serum creatinine
levels [19]. Details of the measurement methods
can be found in the Appendix S1.
Statistical analysis
To obtain a normal distribution, telomere length
was natural-log-transformed. Other continuous
variables with a skewed distribution (creatinine,
insulin, glucose, high-sensitivity C-reactive pro-
tein, cholesterol, HDL and triglycerides) were also
natural-log-transformed prior to analysis. Individ-
uals in the bottom and top 0.5% of the RTL
distribution were excluded to limit the undue
influence of outliers in the regression analysis.
Differences in telomere lengths between groups
were tested using Student’s t-test or one-way ANOVA.
Cross-sectional associations between variables
and telomere length were evaluated using standard
linear regression models. Multivariate linear
regression models were used to adjust for age and
gender. To investigate telomere dynamics across
time, two-level hierarchical growth models were
constructed. Variables were centred around the
grand mean (i.e. the mean was set to zero). Details
of the model-building strategy, centring and mul-
titest correction are provided in the Appendix S1.
Results
At baseline (T1), 8592 individuals participated in
the PREVEND study. DNA was available for 8506
(99%) subjects, andRTLwas successfullymeasured
in 8074 subjects in the present analysis (95% of
those with available DNA samples; see Fig. 1).
Baseline characteristics of these 8074 subjects are
presented in Table 1. The median age of our cohort
at baseline was 48 (range 28–75) years (50% male,
95% Caucasian). As expected, baseline leucocyte
telomere lengthwasassociatedwithage andgender.
In addition, leucocyte telomere length at baseline
was associated with ethnicity, glucose levels and
diabetes, waist–hip ratio and obesity, cholesterol
levels and hypercholesterolaemia, levels of HDL
cholesterol, triglycerides and C-reactive protein,
andcigarette smoking.Within the groupof smokers,
we found a dose-dependent association between the
number of cigarettes smoked per day and baseline
leucocyte telomere length (Tables 1 and 2). All these
associations remained significant after adjustment
for age and gender.
Telomere dynamics
In addition to the measurements at T1 (baseline),
we obtained 8709 follow-up measurements at two
follow-up time-points. At T2 (an average of
4.3 years after T1), the initiation of DNA collection
was half way through follow-up of subjects. There-
fore, of the remaining 6894 subjects in PREVEND,
DNA was available for 3646 (53%) and RTL was
successfully measured in 3412 (94%) subjects. At
T3 (an average of 6.6 years after T1), 5862 partic-
ipated in PREVEND, DNA was available for 5541
(95%) of the subjects and RTL was successfully
measured in 5297 (96%) subjects. Overall, data
were available at all three time-points for 2823
subjects, and at least one follow-up measurement
in addition to the baseline measurement was
obtained for 5886 subjects, who were included in
the longitudinal analysis. Using the unconditional
growth model, we observed an average telomere
attrition rate of 0.47  0.16 RTLU per year in the
longitudinal analysis, which is similar to the
annual attrition rate derived from our baseline
cross-sectional estimates (see Table 1). RTL short-
ened (RTLU decrease of >10%), in 44% of subjects,
was stable (RTLU change of ≤10%) in 22% and
elongated (RTLU increase of >10%) in 34% after a




















Included (all time points)
Fig. 1 Study participants Stacked histogram of subjects
showing the percentage of unavailability of DNA samples
and unsuccessful RTL measurement at each time point
[baseline (T1), first follow-up examination (T2) and second
follow-up examination (T3)] and the percentage of subjects
with successful RTL measurements at all three time-
points.
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A basic growth model consisting of baseline telo-
mere length, gender, age and the age 9 gender
interaction term was constructed (Table 3). Eth-
nicity was considered but not included in the basic
model because inclusion did not lead to any
improvement (Table S1, Appendix S1). Telomere
attrition rate increased with advancing age, and
this effect was more pronounced in men than in
women (P for interaction 0.043; Table 3). This
basic model was then used to evaluate the other
variables shown in Tables 1 and 2. All variables
that caused a significant (P < 0.05) improvement
when added to the basic model are presented in
Table 3. Both higher systolic (P = 0.038) and dia-
stolic (P = 0.031) blood pressures but not hyper-
tension were related to an increased telomere
attrition rate. Similarly, serum triglyceride level
(P < 0.001) but not hypercholesterolaemia or total
cholesterol was related to an increased rate of
telomere attrition, and higher HDL cholesterol
levels were protective (P < 0.001). Finally, other
traits related to the metabolic syndrome, including
the presence of diabetes (P = 0.022) and higher
waist–hip ratio (P < 0.001) and active smoking
were related to accelerated telomere attrition
(P < 0.001). In the longitudinal analysis, there
was no dose-dependent effect of smoking. The
inflammatory marker C-reactive protein was
correlated with baseline telomere length but was
not a significant determinant when added to the
basic growth model in the longitudinal analysis.
Multifactorial model
All variables that showed an effect when added to
the basic model were evaluated together to test
which had the greatest independent effects on
telomere attrition rate. Nonsignificant variables
were removed using a stepwise backward strategy
(excluded variables and their P-values are pre-
sented in Table S2, Appendix S1). In the final
multifactorial model, higher glucose levels, higher
waist–hip ratio, lower HDL cholesterol and active
smoking were identified as the major independent
modifiable factors explaining an increased telo-
mere attrition rate (Table 4 and Fig. 2). For exam-
ple, the annual attrition rate of a female,
nonsmoking subject with average values for
Table 1 Baseline values, and age- and gender-adjusted association with baseline telomere length
Baseline value
(n = 8074) B (95% CI) Standardized B P-valueb
Age (years) 48 [39–60] 0.47 (0.52 to 0.42) 0.21 <0.001
Male gender 4027 (49.9) 2.51 (1.26 to 3.76) 0.04 <0.001
Systolic BP (mmHg) 126 [114–141] 0.03 (0.07 to 0.01) 0.02 0.10
Diastolic BP (mmHg) 73 [67–80] 0.03 (0.10 to 0.04) 0.01 0.43
eGFR (mL min1 1.73 m2) 78.8 [69.9–88.4] 0.02 (0.03 to 0.07) 0.01 0.37
Creatinine (mg dL1) 0.93 [0.84–1.04] 0.03 (0.08 to 0.02)a 0.01 0.29
Insulin (lIU mL1) 1.15 [0.81–1.74] 0.29 (0.44 to 0.14)a 0.04 <0.001
Glucose (mg dL1) 84.7 [77.5–91.9] 176.4 (240.9 to 111.7)a 0.06 <0.001
Body mass index (kg m2) 25.6 [23.1–28.4] 0.23 (0.39 to 0.08) 0.03 <0.01
Waist–hip ratio 0.88 [0.81–0.95] 22.76 (31.88 to 13.65) 0.07 <0.001
C-reactive protein (mg L1) 1.29 [0.56–2.99] 1.82 (2.38 to 1.26)a 0.07 <0.001
Cholesterol (mg dL1) 214.3 [188.8–244.0] 157.5 (285.7 to 29.3)a 0.03 0.02
HDL cholesterol (mg dL1) 49.0 [39.8–60.2] 242.5 (154.1 to 330.9)a 0.07 <0.001
Cholesterol–HDL ratio 4.36 [3.36–5.63] 5.38 (7.25 to 3.51)a 0.07 <0.001
Triglycerides (mg dL1) 102.7 [75.2–149.6] 260.2 (369.9 to 151.3)a 0.05 <0.001
Cigarettes/day
1–6 | 6–20 | >20
447 (16.4) | 1786
(65.4) | 499 (18.3)
2.20 (3.37 to 1.03) <0.001
Data are presented as median [interquartile range] or number (percentage).
BP, blood pressure; eGFR, estimated glomerular filtration rate.
aBeta estimate is for 1 natural-log-transformed unit increase.
bP-value after adjustment for age and gender.
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baseline telomere length, age, glucose, waist–hip
ratio and HDL cholesterol was 0.26 RTLU (equal
to the estimate for ‘follow-up time’ as all other
variables in the model are 0). However, if instead
this same subject was a smoker, the estimated
attrition rate would be 0.94 RTLU (0.26 plus an
additional 0.68 for smoking). In the case of a
female smoker with a glucose level one standard
deviation higher and HDL cholesterol level one
standard deviation lower than average, the
estimated attrition rate would rise to 1.33 RTLU
(0.68 plus 0.13 for glucose and 0.26 for HDL
cholesterol).
Discussion
Here, we describe the first comprehensive evalua-
tion of the determinants of leucocyte telomere
attrition in humans. Our principal findings are
that leucocyte telomere attrition shows wide vari-
ation between individuals, with mainly shortening
but also elongation, and is associated with param-
eters of the metabolic syndrome and smoking.
Although baseline leucocyte telomere length was
the principal determinant of RTL change, we iden-
tified age, gender, glucose levels, waist–hip ratio,
HDL cholesterol and smoking as factors that also
Table 2 Baseline RTL amongst subgroups
n (%) Median T/S (IQR) P-valuea Adjusted P-valueb
Gender
Male 4027 (50) 0.98 (0.82–1.20) <0.001 <0.001
Female 4047 (50) 1.03 (0.84–1.25)
Ethnicity
Caucasian 7664 (95) 0.99 (0.83–1.22)
Black 77 (1) 1.11 (0.91–1.44) 0.01 0.02c
Asian 167 (2) 1.02 (0.85–1.30) 0.06 0.33c
Other 166 (2) 1.07 (0.84–1.28) 0.07 0.29c
Hypertension
Yes 2577 (32) 0.95 (0.79–1.14) <0.001 0.01
Prehypertension 3241 (40) 1.03 (0.84–1.24)
No 2256 (28) 1.04 (0.87–1.29)
Diabetes
Yes 203 (3) 0.92 (0.76–1.11) <0.001 0.02
No 7871 (98) 1.01 (0.83–1.23)
Obesity
Yes 1259 (16) 0.96 (0.80–1.16) <0.001 <0.01
Overweight 3255 (40) 0.98 (0.81–1.21)
No 3473 (43) 1.04 (0.86–1.27)
Hypercholesterolaemia
Yes 1682 (21) 0.96 (0.80–1.16) <0.001 <0.01
Borderline 3713 (46) 0.99 (0.82–1.22)
No 2679 (33) 1.05 (0.87–1.28)
Smoker
Yes 2742 (34) 0.98 (0.81–1.20) <0.001 <0.001
Former 2929 (36) 0.99 (0.83–1.22)
No 2373 (29) 1.04 (0.86–1.27)
IQR, interquartile range.
aP-value for difference between groups.
bAdjusted for age and gender.
cCompared with Caucasians.
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have a substantial effect. For example, the effect of
active smoking increased the yearly attrition rate
by more than threefold. Subjects who stopped
smoking before entering the study still had shorter
baseline leucocyte telomere length, although their
annual attrition rate was comparable to that of
subjects who never smoked.
Based on cell cultures and cross-sectional mea-
surements, it has been assumed that telomere
length of somatic cells can only become shorter
over time. However, this view has recently been
challenged by the findings of several studies mea-
suring leucocyte telomere length on multiple occa-
sions [17, 20, 21]. Our data also support the notion
Table 3 Estimates of annual leucocyte telomere attrition rate
Model Variables included in model Beta estimate (95% CI)
Standardized beta
estimate (95% CI) P-value
Unconditional Follow-up time (years) 0.47 (0.31 to 0.64) <0.001
Basic model Follow-up time (years) 0.22 (0.05 to 0.39) 0.011
Baseline telomere length (RTLU) 10.54 (10.21 to 10.87) 3.97 (4.09 to 3.84) <0.001
Age (per 10 years) 0.52 (0.37 to 0.67) 0.88 (1.04 to 0.71) <0.001
Gendera 0.20 (0.04 to 044) 0.12 (0.24 to 0.01) 0.097
Age 9 gender interactiona 0.21 (0.01 to 0.41) 0.12 (0.25 to 0.01) 0.043
Blood pressure Systolic (per 10 mmHg) 0.07 (0.01 to 0.14) 0.15 (0.29 to 0.01) 0.038
Diastolic (per 10 mmHg) 0.15 (0.01 to 0.29) 0.14 (0.27 to 0.01) 0.031
Metabolic factors Insulin (lIU mL1)b 0.22 (0.01 to 0.42) 0.13 (0.26 to 0.01) 0.039
Glucose (mg dL1)b 1.29 (0.58 to 2.01) 0.22 (0.35 to 0.10) <0.001
Diabetes 0.88 (1.63 to 0.13) 0.12 (0.02 to 0.24) 0.022
Body mass index (kg m2) 0.04 (0.01 to 0.06) 0.14 (0.26 to 0.02) 0.013
Waist–hip ratio (per 0.1 ratio) 0.41 (0.23 to 0.59) 0.37 (0.54 to 0.21) <0.001
HDL cholesterol (mg dL1)b 1.26 (0.82 to 1.71) 0.37 (0.24 to 0.50) <0.001
Triglycerides (mg dL1)b 0.50 (0.27 to 0.74) 0.27 (0.39 to 0.14) <0.001
Smoking Smokingc 0.73 (1.03 to 0.43) 0.29 (0.41 to 0.17) <0.001
aMale = 1, Female = 0.
bBeta estimate is for 1 natural-log-transformed unit increase.
cCompared to nonsmokers.
Table 4 Estimates of annual leucocyte telomere attrition rate in the multifactorial model
Variables included Beta estimate (95% CI) Standardized beta estimate (95% CI) P-value
Follow-up (years) 0.26 (0.02 to 0.53) <0.001
Baseline telomere length (RTLU) 10.70 (10.37 to 11.04) 4.03 (4.15 to 3.90) <0.001
Age (per 10 years) 0.48 (0.32 to 0.64) 0.79 (0.96 to 0.61) <0.001
Gendera 0.31 (0.01 to 0.63) 0.15 (0.01 to 0.32) 0.06
Age 9 gender interactiona 0.21 (0.01 to 0.42) 0.11 (0.31 to 0.01) 0.04
Glucose (mg dL1)b 0.76 (0.02 to 1.51) 0.13 (0.27 to 0.01) 0.04
Waist–hip ratio (per 0.1 ratio) 0.27 (0.07 to 0.46) 0.25 (0.43 to 0.07) <0.01
HDL cholesterol (mg dL1)b 0.91 (0.44 to 1.39) 0.26 (0.12 to 0.40) <0.001
Smokingc 0.67 (0.37 to 0.98) 0.27 (0.39 to 0.15) <0.001
aMale = 1, Female = 0.
bEstimate is for 1 natural-log-transformed unit increase.
cCompared to nonsmokers.
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of a dynamic pattern including shortening and
lengthening of leucocyte telomere length over time.
The time course of these fluctuations is currently
unknown as they were observed after a relatively
long follow-up period of 5–10 years with few mea-
surement time-points. In a recent small-scale study,
a pattern of shortening and lengthening was also
observed over a period of only 12 months, suggest-
ing an oscillating telomere length over time [22].
Despite the observed dynamic pattern of leucocyte
telomere length, we confirmed that the mean RTL of
our population shortened over time. We believe our
observed dynamic pattern of telomere length of
circulating leucocytes is consistent with the hypoth-
esis of Chen et al. [23] that ‘age dependent shorten-
ing is the rule’. The mechanism for this presumed
oscillating telomere length of the circulating leuco-
cyte pool remains unclear; differences in cell frac-
tions or true biological effects, such as transient
telomerase activation, have been suggested [24, 25].
In cross-sectional studies, associations have been
shown between telomere length and age as well as
several other factors including ethnicity [13],
smoking [14], hypertension [26], body mass index
[14, 26], waist–hip ratio [17],and levels of insulin
[7, 26], glucose [26], total cholesterol [27], HDL
cholesterol [28], triglycerides [27] and C-reactive
protein [7]. However, it remains unclear whether
these factors cause leucocyte telomere attrition.
Here, we observed the same cross-sectional asso-
ciations at baseline but have demonstrated that
glucose levels, waist–hip ratio, HDL cholesterol
and smoking have a substantial independent
effect on longitudinal leucocyte telomere attrition.
Some factors, such as blood pressure traits, did
not remain significant after inclusion of multiple
stronger traits, which might be attributed to
colinearity with stronger metabolic traits or lack
of power to detect smaller influences. In addition,
we cannot exclude the presence of bias related to
certain traits. For example, we have insufficient
information to study the potential unrecorded bias
of blood pressure-lowering pharmacotherapy. Our
observation that leucocyte telomere attrition rate
is associated with baseline telomere length, gender
and waist–hip ratio confirms the findings of pre-
vious studies [17, 20, 21]. Because we modelled
the effect of time instead of cross-sectional data,
we add the knowledge that higher age is associ-
ated with a higher leucocyte telomere attrition
rate. Further novel findings are the associations
between leucocyte telomere attrition rate and both
blood glucose levels (negative association) and
HDL cholesterol (positive association). The mech-
anisms linking these factors to faster leucocyte
telomere attrition rates are currently unclear,
although levels of oxidative stress and/or inflam-
mation are likely to have a role. It is interesting
that low-grade inflammation, as assessed by the
level of high-sensitivity C-reactive protein, did not
affect leucocyte telomere attrition rate. This is in
line with an earlier observation, but it should be
recognized that this does not exclude the possibil-
ity of an association with low-grade inflammation
as assessed by other markers [29]. Another pos-
sibility is that oxidative stress could provide a
molecular mechanism for telomere attrition [30]. A
common denominator of higher glucose levels [31],
higher waist–hip ratio [32] and smoking [33] is
increased levels of oxidative stress. HDL, on the
other hand, is known to have antioxidative prop-
erties [34]. It has also been suggested that HDL
signalling pathways intersect with key stress
responses and survival pathways, thereby modu-
lating the ageing process [35]. A potential target of
HDL signalling pathways is c-Jun N-terminal
Fig. 2 Effect size for RTL change in the final model. The
effects of the variables present in the full model on RTL
change. The 0-line represents the basic attrition rate for
nonsmoking subjects when all other centred variables are
0 (mean). The boxes represent the additional telomere
attrition rate for an increase of 10 years for women,
10 years for men and one standard deviation of glucose
concentration, waist–hip ratio and HDL level, respectively.
For smoking, the box represents the additional telomere
attrition for current smokers. The whiskers represent the
95% confidence interval for the estimates.
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kinase, which can be activated by several triggers,
including HDL, and functions as a potent protec-
tive factor in flies [36].
Our findings should be interpreted in the context
of several limitations. The main limitation is that
we studied mean leucocyte telomere length, which
consists of a mixture of different leucocyte sub-
sets with different individual telomere lengths and
does not necessarily translate to other tissues.
Secondly, our study was conducted in a primarily
Caucasian cohort, and therefore, our findings
may not extend to other ethnic populations.
Thirdly, we have insufficient information about
some factors that are associated with healthy
ageing, such as physical activity [37] and dietary
habits [18]. Finally, we were not able to provide a
molecular mechanism to explain the reported
observations.
Nevertheless, it is of great interest that, besides age
and gender and known genetic factors [38, 39], the
factors found to influence leucocyte telomere length
are modifiable and thus present potential targets to
decrease leucocyte telomere shortening. In a recent
study in telomerase-deficient mice, it was demon-
strated that telomerase reactivation through knock-
in of telomerase eliminated degenerative pheno-
types across multiple organs [40]. These findings
suggest that preventing leucocyte telomere short-
ening might have important clinical implications in
the prevention ofmultiple age-related diseases. One
could postulate that modifying smoking behaviour
and metabolic traits will lead to a slower pace of
biological ageing. This might also account for other
factors not investigated in the present study; for
example, blood levels of omega-3 fatty acids [18] and
vigorous physical activity [37] have both been sug-
gested to decelerate leucocyte telomere attrition.
Future studies should address whether interven-
tions aimed at modifying telomere biology indeed
preserve or even increase telomere length and
promote healthy ageing.
In conclusion, we present the results from the
largest study measuring leucocyte telomere length
to date and provide novel evidence for a longitudi-
nal association between accelerated telomere loss
and several factors: high blood glucose levels,
increased waist–hip ratio, reduced blood HDL
cholesterol levels and smoking. This finding sup-
ports the hypothesis that modifiable lifestyle fac-
tors influence the pace of biological ageing and
provides a mechanistic link to an increased risk of
numerous age-associated diseases. Whether alter-
ing telomere dynamics could impact on healthy
ageing requires further confirmation.
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